These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 4430415
1. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Gerich JE, Lorenzi M, Schneider V, Kwan CW, Karam JH, Guillemin R, Forsham PH. Diabetes; 1974 Nov; 23(11):876-80. PubMed ID: 4430415 [No Abstract] [Full Text] [Related]
2. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J, Gale CC. Science; 1974 Apr 26; 184(4135):482-4. PubMed ID: 4594711 [Abstract] [Full Text] [Related]
3. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. Gerich JE, Lorenzi M, Schneider V, Karam JH, Rivier J, Guillemin R, Forsham PH. N Engl J Med; 1974 Sep 12; 291(11):544-7. PubMed ID: 4604408 [No Abstract] [Full Text] [Related]
4. Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster. Frankel BJ, Gerich JE, Fanska RE, Gerritsen GC, Grodsky GM. Diabetes; 1975 Mar 12; 24(3):273-9. PubMed ID: 1116650 [Abstract] [Full Text] [Related]
5. Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas. Efendić S, Claro A, Laft R. Acta Endocrinol (Copenh); 1976 Apr 12; 81(4):753-61. PubMed ID: 946565 [Abstract] [Full Text] [Related]
6. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Johnson DG, Ensinck JW, Koerker D, Palmer J, Goodner CJ. Endocrinology; 1975 Feb 12; 96(2):370-4. PubMed ID: 1089535 [Abstract] [Full Text] [Related]
7. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects. Sgambato S, Passariello N, Giugliano D, Torella R, D'Onofrio F. Acta Diabetol Lat; 1981 Feb 12; 18(3):235-41. PubMed ID: 7029989 [Abstract] [Full Text] [Related]
8. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. Rizza R, Verdonk C, Miles J, Service FJ, Gerich J. J Clin Invest; 1979 Jun 12; 63(6):1119-23. PubMed ID: 447838 [Abstract] [Full Text] [Related]
17. Abnormalities of endogenous glucagon and insulin in unstable diabetes. Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS. Diabetes; 1977 Jan 12; 26(1):36-45. PubMed ID: 830563 [Abstract] [Full Text] [Related]
18. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus. Ward FR, Leblanc H, Yen SS. J Clin Endocrinol Metab; 1975 Sep 12; 41(3):527-32. PubMed ID: 1159060 [Abstract] [Full Text] [Related]
19. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)]. Baumeister G, Wagner H, Stahl M. Klin Wochenschr; 1975 Jun 15; 53(12):571-4. PubMed ID: 811925 [Abstract] [Full Text] [Related]
20. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics]. Cucinotta D, Quartarone M, Saitta A, Sardo A, Squadrito G. Boll Soc Ital Biol Sper; 1978 Nov 30; 54(22):2290-6. PubMed ID: 754729 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]